Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source

Virus Research

Volumn 158, Issue 1-2, 2011, Pages 89-97

  Ravikumar, Y S ^a   Ray, Upasana ^a   Nandhitha, M ^a   Perween, Ashiya ^b   Raja Naika, H ^a   Khanna, Navin ^b   Das, Saumitra ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

Antiviral herbals; Hepatitis C; NS3 protease; NS5B polymerase; Replication inhibition

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACTIN; ALPHA INTERFERON; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5B; PHYLLANTHUS AMARUS EXTRACT; RNA DIRECTED RNA POLYMERASE; VIRUS ENZYME; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG POTENTIATION; DRUG SCREENING; ENZYME ASSAY; ENZYME INHIBITION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PLANT LEAF; PLANT ROOT; PRIORITY JOURNAL; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; REPLICON; RNA REPLICATION; VIRUS INHIBITION;

ANTIVIRAL AGENTS; CELL LINE; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; HEPACIVIRUS; HUMANS; MICROBIAL SENSITIVITY TESTS; PHYLLANTHUS; PLANT EXTRACTS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS; PHYLLANTHUS AMARUS;

EID: 79956326437     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.03.014     Document Type: Article

References (28)

1. Bartenschlager R. Hepatitis C virus replicons: potential role for drug development. Nat. Rev. Drug Dis. 2002, 1:911-916.
2. Berdichevsky Y., Zemel R., Bachmatov L., Abramovichb A., Koren R., Sathiyamoorthy P., Golan-Goldhirsh A., Tur-Kaspa R., Benhar I. A novel high throughput screening assay for HCV NS3 serine protease inhibitors. J. Virol. Methods 2003, 107:245-255.
3. Chen K.X., Vibulbhan B., Yang W., Nair L.G., Tong X., Cheng Kuo-Chi, Njoroge F.G. Novel potent inhibitors of hepatitis C virus (HCV) NS3 protease with cyclic sulfonyl P3 cappings. Bioorg. Med. Chem. Lett. 2009, 19:1105-1109.
4. Dholwani K.K., Saluja A.K., Guptha A.R., Shah D.R. A review on plant-derived natural products and their analogs with antitumour activity. Ind. J. Pharmacol. 2008, 40:49-58.
5. Forestier N., Reesink H.W., Weegink C.J., McNair L., Kieffer T.L., Chu H.M., Purdy S., Jansen P.L.M., Zeuzem S. Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C. Hepatology 2007, 46:640-648.
6. Fuerst T.R., Niles E.G., Studie F.W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:8122-8126.
7. Frese M., Barth K., Kaul A., Lohmann V., Schwarzle V., Bartenschlager R. Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha. J. Gen. Virol. 2003, 84:1253-1259.
8. Harvey A.L. Natural products in drug discovery. Drug Discov. Today 2008, 13:894-901.
9. Hussein G., Miyashiro H., Nakamura N., Hattori M., Kakiuchi N., Shimotohno K. Inhibitory effects of sudanese medicinal plant extracts on hepatitis C virus (hcv) protease. Phytother. Res. 2000, 14:510-516.
10. Kato T., Date T., Miyamoto M., Sugiyama M., Tanaka Y., Orito E., Ohno T., Sugihara K., Hasegawa I., Fujiwara K., Ito K., Ozasa A., Mizokami M., Wakita T. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system. J. Clin. Microbiol. 2005, 43:5679-5684.
11. Kitazato K., Wang Y., Kobayashi N. Viral infectious disease and natural products with antiviral activity. Drug Discov. Ther. 2007, 1:14-22.
12. Lenz O., Verbinnen T., Lin T.I., Vijgen L., Maxwell Cummings D., Lindberg J., Berke J.M., Dehertogh P., Fransen E., Scholliers A., Vermeiren K., Ivens T., Raboisson P., Edlund M., Storm S., Vrang L., de Kock H., Fanning G.C., Simmen K.A. In vitro resistance profile of the hepatitis C virus ns3/4a protease inhibitor tmc435. Antimicro Age Chemother. 2010, 54:1878-1887.
13. Lin K., PerniKwong R.B., Lin A.D.C. VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in hcv replicon cells. Antimicro Age Chemother. 2006, 50:1813-1822.
14. Lorenz I.C., Marcotrigiano J., Dentzer T.G., Rice C.M. Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature 2006, 442:831-835.
15. Loske C., Neumann A., Cunningham A.M., Nichol N., Schinzel R., Riederer P., Münch G. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J. Neural Transm. 1998, 105:1005-1015.
16. Ma Y., Yates J., Liang Y., Lemon S.M., Yi M. NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J. Virol. 2008, 82:7624-7639.
17. Randall G., Grakoui A., Rice C.M. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:235-240.
18. Ray P.S., Grover R., Das S. Two internal ribosome entry sites mediate the translation of p53 isoforms. EMBO Rep. 2006, 7:404-410.
19. Reesink H.W., Zeuzem S., Weegink C.J., Forestier N., van Vliet A., van de Wetering de Rooij J., McNair L., Purdy S., Kauffman R., Alam J., Jansen P.L. Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study. Gastroenterology 2006, 131:997-1002.
20. Sarrazin C., Rouzier R., Wagner F., Forestier N., Larrey D., Gupta S.K., Hussain M., Shah A., Cutler D., Zhang J., Zeuzem S. SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders. Gastroenterology 2007, 132:1270-1278.
21. Schregel V., Jacobi S., Penin F., Tautz N. Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5342-5347.
22. Strader D.B., Wright T., Thomas D.L., Seeff L.B. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004, 39:1147-1171.
23. Sule M.I., Haruna A.K., Pateh U.U., Ahmadu A.A., Ambi A.A., Sallau M.S. Phytochemical investigations of leaf, fruit and root bark of Olax manni Oliv. Olacaceae Chem. Class J. 2005, 2:22-24.
24. Thyagarajan S.P., Thirunalasundari T., Subramanian S., Venkateswaran P.S., Blumberg B.S. Effect of Phyllanthus amarus on chronic carriers of hepatitis B Virus. Lancet 1988, 332:764-766.
25. Tiwari A., Jadon R.S., Tiwari P., Nayak S. Phytochemical investigations of crown of Solanum melongena fruit. Int. J. Phytomed. 2009, 1:9-11.
26. Welbourn S., Pause A. The hepatitis C virus NS2/3 protease. Curr. Issues Mol. Biol. 2007, 9:63-70.
27. Yi M., Ma Y., Yates J., Lemon S.M. Compensatory mutations in E1, p7, NS2 and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J. Virol. 2006, 81:629-638.
28. Zeisel M.B., Baumert T.F. Production of infectious hepatitis C virus in tissue culture: A breakthrough for basic and applied research. J. Hepatol. 2006, 44:436-439.